Loading...
NPI 1962921445 · Richardson, TX · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Cabot Lab LLC is a clinical medical laboratory provider located in Richardson, Texas. This profile covers 53 Medicare and 29 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Cabot Lab LLC |
| Address | 833 E Arapaho Rd Ste 105 |
| City | Richardson |
| State | TX |
| ZIP | 75081 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | September 15, 2017 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $1.2M |
| Medicare | $278.1K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
53 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 81185 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the calcium voltage–gated channel subunit alpha1 A gene, also called CACNA1A. | 40 | $830 | $31.5K |
| 81325 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the peripheral myelin protein 22, or PMP22, gene. | 40 | $750 | $27.1K |
| 81302 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the methyl CpG binding protein 2, or MECP2 gene. | 40 | $520 | $19.6K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 440 | $30 | $15K |
| 81364 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the hemoglobin, subunit beta (HBB) gene. | 40 | $320 | $12.4K |
| 81309 | The lab analyst performs the technical lab test to analyze specific gene sequences of the phosphatidylinositol–4, 5–biphosphate 3–kinase, catalytic subunit alpha (PIK3CA) gene. | 40 | $270 | $10K |
| 81189 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the cystatin B gene (CSTB). | 40 | $270 | $9.7K |
| 81286 | The lab analyst performs the technical lab test to analyze the entire gene sequence for the frataxin gene (FXN). | 40 | $270 | $9.4K |
| 81192 | The lab analyst performs the technical lab test using a specimen such as formalin–fixed paraffin embedded tissue (FFPE) to analyze NTRK2 (neurotrophic receptor tyrosine kinase 2) translocations that… | 40 | $200 | $8.5K |
| 81249 | The lab analyst performs the technical lab test to analyze known the full gene sequence of the glucose–6–phosphate dehydrogenase (G6PD) gene. | 10 | $590 | $8.2K |
Showing 1–10 of 53
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 53 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
53 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81185 | 8 | 10 | 110 | $820 | $906.1K |
| 81325 | 7 | 10 | 90 | $750 | $582.2K |
| 81302 | 8 | 10 | 90 | $520 | $479.9K |
| 81249 | 21 | 20 | 80 | $590 | $319.2K |
| 81309 | 8 | 10 | 110 | $270 | $278.9K |
| 81189 | 8 | 10 | 110 | $270 | $278.2K |
| 87798 | 182 | 300 | 790 | $30 | $265.1K |
| 81286 | 7 | 10 | 90 | $270 | $207K |
| 81223 | 23 | 30 | 70 | $450 | $197.4K |
| 81192 | 7 | 10 | 110 | $200 | $181.3K |
Showing 1–10 of 53
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
29 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 11,890 | $60 | $653.9K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 12,740 | $20 | $293.1K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 16,580 | $10 | $232.1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 2,870 | $20 | $54.6K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 830 | $1 | $2.5K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 610 | $1 | $1.2K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 240 | $10 | $1.2K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 240 | $10 | $1.2K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 200 | $10 | $1K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 440 | $1 | $880 |
Showing 1–10 of 29
How this provider's Medicaid billing volume and revenue compare to other Texas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Texas median
29 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 29 | 340 | 400 | $50 | $553.5K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 122 | 160 | 200 | $280 | $321.8K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 104 | 240 | 420 | $30 | $296.8K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 167 | 290 | 410 | $20 | $225K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 169 | 300 | 410 | $20 | $223.4K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 86 | 150 | 320 | $20 | $184K |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 41 | 110 | 360 | $40 | $174.9K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 46 | 100 | 650 | $50 | $161.3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 66 | 260 | 640 | $20 | $137.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 138 | 350 | 510 | $30 | $114.1K |
Showing 1–10 of 29
Other providers in the same ZIP code as Cabot Lab LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Caregivers Home Health Tx Inc | TX | Home Health Agency | $0 | $478M |
| Apple Homecare Medical Supply LLC | TX | Durable Medical Equipment & Medical Supplies | $0 | $123.3M |
| Hope Pediatrics LLC | TX | Home Health Agency | $0 | $77.9M |
| Abc Home Medical Supply, Inc. | TX | Durable Medical Equipment & Medical Supplies | $0 | $22.8M |
| Trident Diagnostics Limited Liability Company | TX | Clinical Medical Laboratory | $14.9M | $66.7K |
| Rfa Medical Solutions LLC | TX | Clinical Medical Laboratory | $6.4M | $0 |
| Curie Dx Laboratory LLC | TX | Clinical Medical Laboratory | $664.4K | $2.8K |
| Shahida Rafiq | TX | Family Medicine Physician | $232.7K | $0 |
| Pearl Ezegrim | TX | Psychiatric/Mental Health Nurse Practitioner | $110.1K | $40 |
| Francis Lister | TX | Optometrist | $23.8K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.